Auckland, New Zealand

Reena Daken

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fisher & Paykel Healthcare Limited. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reena Daken. Retrieved from https://idiyas.com/inventor/reena-daken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0



Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Reena Daken

Introduction: Reena Daken, a pioneering inventor hailing from Auckland, New Zealand, has made significant contributions to the world of technology and innovation.

Latest Patents: Reena Daken's latest patents include groundbreaking inventions in the field of renewable energy and sustainable materials, showcasing her commitment to environmental conservation.

Career Highlights: Throughout her illustrious career, Reena Daken has been recognized for her innovative spirit and problem-solving abilities, leading to the development of cutting-edge solutions in various industries.

Collaborations: Reena Daken has collaborated with leading research institutions and universities worldwide, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: In conclusion, Reena Daken's passion for innovation and dedication to creating a positive impact on society through her inventions solidify her position as a trailblazer in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…